https://businessdailyswitzerland.com/article/906283666-en-suisse-romande-36-de-la-population-a-d-j-t-victime-d-une-fraude-ou-d-une-tentative-de-fraude-sur-smartphone Business Daily Switzerland en PressRelease 2026-04-21T05:50:00+00:00 En Suisse romande, 36% de la population a déjà été victime d'une fraude ou d'une tentative de fraude sur smartphone https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835065-smartphone-3840x2160.jpeg https://businessdailyswitzerland.com/article/906284609-in-der-schweiz-war-bereits-ein-drittel-der-bev-lkerung-opfer-eines-betrugs-oder-eines-betrugsversuchs-auf-dem-smartphone Business Daily Switzerland en PressRelease 2026-04-21T05:50:00+00:00 In der Schweiz war bereits ein Drittel der Bevölkerung Opfer eines Betrugs oder eines Betrugsversuchs auf dem Smartphone https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835065-smartphone-3840x2160.jpeg https://businessdailyswitzerland.com/article/907074659-addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-in-non-human-primate-chronic-cough-model Business Daily Switzerland en PressRelease 2026-04-21T05:00:00+00:00 Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://businessdailyswitzerland.com/article/906922944-revmate-franchit-un-cap-strat-gique-et-valide-son-mod-le-avec-des-gains-mesurables-en-revenue-management-multi-h-tel Business Daily Switzerland en PressRelease 2026-04-20T12:00:00+00:00 RevMate franchit un cap stratégique et valide son modèle avec des gains mesurables en revenue management multi-hôtel https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836140-revmate-lancement-2026-2659x2659.png https://businessdailyswitzerland.com/article/906786185-molecular-partners-presents-three-posters-at-aacr-2026-with-new-preclinical-data-for-first-switch-darpin-t-cell-engager-mp0632-and-dll3-radio-darpin Business Daily Switzerland en PressRelease 2026-04-19T16:00:00+00:00 Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg